Byline |
D Sanchez-Parcerisa1,2 *, A Gemmel1 , K Parodi2 , O Jäkel3 , E Rietzel1 , (1) Siemens Healthcare Sector, Imaging & Therapy Division, Particle Therapy, Erlangen, Germany (2) Heidelberg Ion Therapy Center (HIT) and Department of Radiation Oncology, Heidelberg, Germany (3) German Cancer Research Center (DKFZ), Dep. Radiation Oncology and Radiotherapy, University Heidelberg, Germany
|